Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quest Diagnostics Inc (DGX)

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,377,110
  • Shares Outstanding, K 117,365
  • Annual Sales, $ 10,788 M
  • Annual Income, $ 1,995 M
  • 60-Month Beta 1.05
  • Price/Sales 1.53
  • Price/Cash Flow 7.74
  • Price/Book 2.58
Trade DGX with:

Options Overview Details

View History
  • Implied Volatility 28.10% ( -1.41%)
  • Historical Volatility 26.73%
  • IV Percentile 73%
  • IV Rank 53.76%
  • IV High 36.86% on 01/24/22
  • IV Low 17.91% on 07/30/21
  • Put/Call Vol Ratio 1.47
  • Today's Volume 143
  • Volume Avg (30-Day) 384
  • Put/Call OI Ratio 0.84
  • Today's Open Interest 11,835
  • Open Int (30-Day) 18,834

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 2.16
  • Number of Estimates 7
  • High Estimate 2.33
  • Low Estimate 1.69
  • Prior Year 3.18
  • Growth Rate Est. (year over year) -32.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.20 +6.78%
on 05/02/22
142.66 -1.80%
on 05/20/22
+2.90 (+2.11%)
since 04/22/22
3-Month
129.59 +8.10%
on 02/28/22
146.43 -4.33%
on 03/18/22
+10.58 (+8.17%)
since 02/24/22
52-Week
125.77 +11.39%
on 02/24/22
174.16 -19.56%
on 12/31/21
+9.62 (+7.37%)
since 05/24/21

Most Recent Stories

More News
Here's Why You Should Retain Quest Diagnostics (DGX) Stock Now

Investors are optimistic about Quest Diagnostics (DGX) owing to a strong recovery in base business and raised 2022 outlook.

UNH : 497.56 (+1.11%)
DGX : 140.09 (+0.39%)
AMN : 88.13 (+0.05%)
STE : 228.57 (+0.45%)
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down

Based on a bullish expectation for the remainder of 2022, Quest Diagnostics (DGX) raises its full-year guidance.

VIVO : 25.97 (-0.04%)
DGX : 140.09 (+0.39%)
NSTG : 15.64 (-5.50%)
LHDX : 2.05 (-2.84%)
Quest Diagnostics (DGX) Beats Q1 Earnings Estimates

Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.65% and 1.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

DGX : 140.09 (+0.39%)
HNGR : 15.61 (+2.97%)
Should You Buy Quest Diagnostics (DGX) Ahead of Earnings?

Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

DGX : 140.09 (+0.39%)
Quest Diagnostics (DGX) Q1 Earnings to Grow on Base Business

Quest Diagnostics (DGX) is expected to report a strong first half of Q1 with a growing number of cases and then a dull second half on gradual stabilization in testing demand.

VIVO : 25.97 (-0.04%)
DGX : 140.09 (+0.39%)
NSTG : 15.64 (-5.50%)
LHDX : 2.05 (-2.84%)
Quest Diagnostics (DGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

DGX : 140.09 (+0.39%)
Quest Diagnostics (DGX) Inks New Diabetic Retinal Imaging Deal

Quest Diagnostics' (DGX) new collaboration with IRIS will enhance access to diabetic retinopathy screening in the United States.

DGX : 140.09 (+0.39%)
OMI : 33.69 (-2.69%)
MCK : 328.80 (+0.36%)
NXGN : 17.90 (+1.24%)
Stocks Climb on Positive Corporate News

Morning Markets June S&P 500 futures this morning are up +0.23%. A +25% surge in shares of Twitter this morning is lifting stock index futures after regulatory filings showed Elon Musk took a 9.2% stake...

TSLA : 628.16 (-6.93%)
TWTR : 35.76 (-5.55%)
BILI : 18.69 (-11.96%)
DIDI : 1.4800 (+2.78%)
PDD : 36.96 (-8.63%)
BABA : 82.47 (-5.46%)
JD : 49.58 (-7.03%)
BIDU : 115.73 (-6.67%)
NIO : 14.63 (-8.56%)
OLLI : 42.01 (-2.73%)
SBUX : 72.72 (-0.95%)
BAX : 73.90 (+0.72%)
Quest Diagnostics' (DGX) Volumes Aid, Price Pressure Stays

According to Quest Diagnostics (DGX), the delay of the 2022 PAMA cuts announced last year proved beneficial for the industry and Medicare beneficiaries.

DGX : 140.09 (+0.39%)
MCK : 328.80 (+0.36%)
HSIC : 83.94 (-0.92%)
IDXX : 362.16 (-1.68%)
Quest Diagnostics' (DGX) New Contract to Aid COVID-19 Research

Quest Diagnostics' (DGX) COVID-19 serological tests, nationwide reach and data analytics capabilities will help assess COVID-19 vulnerability throughout the country.

DGX : 140.09 (+0.39%)
MCK : 328.80 (+0.36%)
HSIC : 83.94 (-0.92%)
IDXX : 362.16 (-1.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services...

See More

Key Turning Points

3rd Resistance Point 143.61
2nd Resistance Point 142.38
1st Resistance Point 141.24
Last Price 140.09
1st Support Level 138.87
2nd Support Level 137.64
3rd Support Level 136.50

See More

52-Week High 174.16
Fibonacci 61.8% 155.68
Fibonacci 50% 149.96
Fibonacci 38.2% 144.25
Last Price 140.09
52-Week Low 125.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar